Synovics Pharmaceuticals Net Income
| SYVC Stock | USD 0.0001 0.00 0.00% |
In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Synovics Pharmaceuticals, as well as the relationship between them.
Synovics Pharmaceuticals' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Synovics Pharmaceuticals' valuation are provided below:Synovics Pharmaceuticals does not presently have any fundamental trend indicators for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Will Pharmaceuticals sector continue expanding? Could Synovics diversify its offerings? Factors like these will boost the valuation of Synovics Pharmaceuticals. If investors know Synovics will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Synovics Pharmaceuticals data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding Synovics Pharmaceuticals requires distinguishing between market price and book value, where the latter reflects Synovics's accounting equity. The concept of intrinsic value - what Synovics Pharmaceuticals' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Synovics Pharmaceuticals' price substantially above or below its fundamental value.
Please note, there is a significant difference between Synovics Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Synovics Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Synovics Pharmaceuticals' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Synovics Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Synovics Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Synovics Pharmaceuticals.
| 11/17/2025 |
| 02/15/2026 |
If you would invest 0.00 in Synovics Pharmaceuticals on November 17, 2025 and sell it all today you would earn a total of 0.00 from holding Synovics Pharmaceuticals or generate 0.0% return on investment in Synovics Pharmaceuticals over 90 days. Synovics Pharmaceuticals, Inc., through its subsidiaries, engages in the development, manufacture, and commercialization... More
Synovics Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Synovics Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Synovics Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
Synovics Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Synovics Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Synovics Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Synovics Pharmaceuticals historical prices to predict the future Synovics Pharmaceuticals' volatility.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Synovics Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Synovics Pharmaceuticals Backtested Returns
We have found three technical indicators for Synovics Pharmaceuticals, which you can use to evaluate the volatility of the company. The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and Synovics Pharmaceuticals are completely uncorrelated.
Auto-correlation | 1.00 |
Perfect predictability
Synovics Pharmaceuticals has perfect predictability. Overlapping area represents the amount of predictability between Synovics Pharmaceuticals time series from 17th of November 2025 to 1st of January 2026 and 1st of January 2026 to 15th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Synovics Pharmaceuticals price movement. The serial correlation of 1.0 indicates that 100.0% of current Synovics Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 1.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Synovics Pharmaceuticals reported net income of (4.01 Million). This is much lower than that of the Pharmaceuticals sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is notably higher than that of the company.
Synovics Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Synovics Pharmaceuticals' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Synovics Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Synovics Pharmaceuticals by comparing valuation metrics of similar companies.Synovics Pharmaceuticals is currently under evaluation in net income category among its peers.
Synovics Fundamentals
| Return On Equity | -3.14 | ||||
| Return On Asset | -0.13 | ||||
| Profit Margin | (0.26) % | ||||
| Operating Margin | (1.18) % | ||||
| Current Valuation | 894.82 K | ||||
| Shares Outstanding | 29.83 M | ||||
| Price To Sales | 0.03 X | ||||
| Revenue | 25.96 M | ||||
| Gross Profit | 4.47 M | ||||
| EBITDA | (3.64 M) | ||||
| Net Income | (4.01 M) | ||||
| Cash And Equivalents | 129.86 K | ||||
| Total Debt | 2.1 M | ||||
| Current Ratio | 0.27 X | ||||
| Book Value Per Share | (0.06) X | ||||
| Cash Flow From Operations | 3.86 M | ||||
| Number Of Employees | 155 | ||||
| Beta | 166.89 | ||||
| Market Capitalization | 542.86 K | ||||
| Total Asset | 22.35 M | ||||
| Retained Earnings | (78.65 M) | ||||
| Working Capital | (12.87 M) | ||||
| Current Asset | 4.68 M | ||||
| Current Liabilities | 17.55 M | ||||
| Net Asset | 22.35 M |
About Synovics Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Synovics Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Synovics Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Synovics Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Synovics Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Synovics Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Synovics Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Synovics Pharmaceuticals Stock:Check out For information on how to trade Synovics Stock refer to our How to Trade Synovics Stock guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Will Pharmaceuticals sector continue expanding? Could Synovics diversify its offerings? Factors like these will boost the valuation of Synovics Pharmaceuticals. If investors know Synovics will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Synovics Pharmaceuticals data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding Synovics Pharmaceuticals requires distinguishing between market price and book value, where the latter reflects Synovics's accounting equity. The concept of intrinsic value - what Synovics Pharmaceuticals' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Synovics Pharmaceuticals' price substantially above or below its fundamental value.
Please note, there is a significant difference between Synovics Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Synovics Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Synovics Pharmaceuticals' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.